Friday, 16 October 2026European Markets

HØLAND OG SETSKOG And SPAREBANKEN MØRE Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(VIANEWS) - HØLAND OG SETSKOG (HSPG.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Financial Services sector.

Financial Asset Price Forward Dividend Yield Return on Equity
HØLAND OG SETSKOG (HSPG.OL) kr124.00 5.34% 5.66%
SPAREBANKEN MØRE (MORG.OL) kr87.10 4.59% 12.57%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. HØLAND OG SETSKOG (HSPG.OL)

5.34% Forward Dividend Yield and 5.66% Return On Equity

Høland og Setskog Sparebank provides banking services for the personal and corporate markets in Norway. It offers savings and pension accounts; consumer loans, business loans, mortgage loans, car loans, and loans for motorbikes, ATVs, motorhomes, caravans, snowmobiles, and boats; and refinancing, credit cards, mobile and online banking, bank guarantee, overdrafts, leasing, and factoring and invoice sales, as well as insurance products. The company was formerly known as Holand Sparebank and changed its name to Høland og Setskog Sparebank in 2010. Høland og Setskog Sparebank was founded in 1849 and is headquartered in Bjørkelangen, Norway.

Earnings Per Share

As for profitability, HØLAND OG SETSKOG has a trailing twelve months EPS of kr9.53.

PE Ratio

HØLAND OG SETSKOG has a trailing twelve months price to earnings ratio of 13.01. Meaning, the purchaser of the share is investing kr13.01 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.66%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Mar 10, 2023, the estimated forward annual dividend rate is 7 and the estimated forward annual dividend yield is 5.34%.

Sales Growth

HØLAND OG SETSKOG's sales growth for the current quarter is negative 3.7%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 23.1%, now sitting on 153.58M for the twelve trailing months.

Volatility

HØLAND OG SETSKOG's last week, last month's, and last quarter's current intraday variation average was a negative 1.54%, a positive 0.37%, and a positive 3.33%.

HØLAND OG SETSKOG's highest amplitude of average volatility was 3.12% (last week), 3.61% (last month), and 3.33% (last quarter).

More news about HØLAND OG SETSKOG.

2. SPAREBANKEN MØRE (MORG.OL)

4.59% Forward Dividend Yield and 12.57% Return On Equity

Sparebanken Møre, together with its subsidiaries, provides banking services for retail and corporate customers in Norway. It operates through Retail and Real Estate Brokerage segments. The company offers services in the areas of financing, deposits and other forms of investments, payment transfers, financial advisory services, asset management, insurance, and real estate brokerage. Sparebanken Møre was founded in 1843 and is headquartered in Ålesund, Norway.

Earnings Per Share

As for profitability, SPAREBANKEN MØRE has a trailing twelve months EPS of kr16.8.

PE Ratio

SPAREBANKEN MØRE has a trailing twelve months price to earnings ratio of 5.18. Meaning, the purchaser of the share is investing kr5.18 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.57%.

Moving Average

SPAREBANKEN MØRE's value is higher than its 50-day moving average of kr85.00 and way higher than its 200-day moving average of kr78.90.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SPAREBANKEN MØRE's stock is considered to be oversold (<=20).

More news about SPAREBANKEN MØRE.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com